Diclofenacum natricum
Dicloratio retard 100 and Diclofenac-ratiopharm are different trade names for the same medicine.
Dicloratio retard 100 belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs), which are used to treat pain and inflammatory conditions.
Dicloratio retard 100 relieves the symptoms of inflammatory conditions, such as swelling and pain. It does not affect the causes of inflammatory conditions and fever.
Dicloratio retard 100 can be used to treat pain and inflammatory conditions, in cases of:
In case of doubts about the action or reasons for prescribing Dicloratio retard 100, you should consult a doctor.
You should follow all the instructions given by your doctor or pharmacist carefully, even if they differ from the general information contained in this leaflet.
If any of the above symptoms occur in the patient, they should inform their doctor and not take Dicloratio retard 100 until the doctor determines that the medicine is suitable for the patient.
Dicloratio retard 100 should not be taken by children and adolescents.
Before starting to take Dicloratio retard 100, the patient should discuss it with their doctor, pharmacist, or nurse.
The patient should inform their doctor if:
Before taking diclofenac, the patient should inform their doctor
Before taking Dicloratio retard 100, the patient should tell their doctor if they have recently undergone or are scheduled to undergo stomach or gastrointestinal surgery, as Dicloratio retard 100 may sometimes cause weakening of the intestinal wound healing process after surgery.
The occurrence of side effects can be limited by taking the medicine in the smallest effective dose and for no longer than necessary.
If any of the above warnings apply to the patient, they should inform their doctor before taking Dicloratio retard 100.
Other special warnings
Dicloratio retard 100 should not be taken at the same time as other systemic NSAIDs, including selective cyclooxygenase-2 inhibitors.
Taking medicines like Dicloratio retard 100 may be associated with a small increased risk of heart attack or stroke. Any risk is more likely after taking high doses and long-term treatment. The recommended dose or treatment duration should not be exceeded.
In case of heart problems, a history of stroke, or suspected risk of these disorders (e.g., high blood pressure, diabetes, high cholesterol, or smoking), the patient should discuss the treatment with their doctor or pharmacist.
Dicloratio retard 100 may reduce the symptoms of infection (e.g., headache, high temperature), making it more difficult to diagnose and treat the infection effectively. If the patient feels unwell and needs to see a doctor, they should inform the doctor that they are taking Dicloratio retard 100.
In very rare cases, Dicloratio retard 100, like other anti-inflammatory medicines, may cause severe allergic skin reactions (e.g., exfoliative dermatitis, Stevens-Johnson syndrome with widespread rash, high fever, and joint pain, and toxic epidermal necrolysis with skin and mucous membrane lesions, high fever, and severe general condition). Therefore, the patient should inform their doctor if such reactions occur. In rare cases, Dicloratio retard 100, like other anti-inflammatory medicines, may cause allergic reactions, including severe allergic reactions, even if the medicine has not been taken before.
Elderly patients
Elderly patients may be more sensitive to the effects of Dicloratio retard 100. Therefore, they should follow their doctor's instructions carefully and take the minimum effective dose for the shortest necessary period to relieve symptoms. It is particularly important for patients to report any side effects to their doctor immediately.
The patient should tell their doctor or pharmacist about all the medicines they are taking, have recently taken, or plan to take.
It is particularly important to inform the doctor about taking any of the following medicines:
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
Dicloratio retard 100 should not be taken during the first and second trimesters of pregnancy, unless it is necessary. When diclofenac is taken by women planning to become pregnant or during the first and second trimesters of pregnancy, the lowest possible dose and shortest duration of treatment should be used.
Dicloratio retard 100 should not be taken during the last three months of pregnancy, as it may harm the baby or cause delayed or accelerated labor.
The patient should not breastfeed if they are taking Dicloratio retard 100, as the medicine may have a harmful effect on the baby.
Diclofenac may make it more difficult to become pregnant. The patient should inform their doctor if they plan to become pregnant or are having trouble becoming pregnant.
The patient should not drive or operate any tools or machines if they experience side effects while taking Dicloratio retard 100, such as vision disturbances, dizziness, drowsiness, or other central nervous system disorders.
Lactose
If the patient has been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicine.
Sodium
The medicine contains less than 1 mmol (23 mg) of sodium per prolonged-release capsule, which means the medicine is considered "sodium-free".
This medicine should always be taken as directed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist.
The doctor will tell the patient exactly how to take Dicloratio retard 100. Depending on the individual patient's response to treatment, the doctor may recommend a higher or lower dose of the medicine.
The patient should not exceed the recommended dose. It is important to take the smallest effective dose for the shortest necessary period to control symptoms and not to take Dicloratio retard 100 for longer than necessary.
The doctor will tell the patient exactly how to take Dicloratio retard 100. Depending on the individual patient's response to treatment, the doctor may recommend a higher or lower dose of the medicine.
Adults
The recommended initial daily dose is 100 mg to 150 mg.
The recommended dose for adults is 1 capsule per day (100 mg of diclofenac sodium), unless the doctor recommends otherwise.
If necessary, therapy may be combined with a dose of 25 mg or 50 mg in the form of tablets or suppositories to a maximum dose of 150 mg of diclofenac sodium per day.
Patients with renal and hepatic impairment
In patients with mild and moderate renal or hepatic impairment, there is no need to adjust the dose.
Elderly patients
When taking Dicloratio retard 100 in elderly patients, special caution should be exercised, and the smallest effective dose should be used for the shortest necessary period to relieve symptoms. The possibility of gastrointestinal bleeding should be regularly monitored.
Children and adolescents
Dicloratio retard 100 should not be taken by children and adolescents.
The capsules should be swallowed whole before meals, without chewing, and washed down with a glass of water.
The patient should not exceed the recommended dose.
The patient should strictly follow their doctor's instructions.
If the patient has accidentally taken a higher dose of Dicloratio retard 100 than recommended, they should inform their doctor or pharmacist or go to the hospital emergency department immediately. Medical attention may be necessary.
If the patient misses a dose, they should take it as soon as they remember. If it is almost time for the next dose, the patient should take the next dose at the usual time. The patient should not take a double dose to make up for the missed dose.
If the patient has any further doubts about taking this medicine, they should consult their doctor or pharmacist.
Like all medicines, Dicloratio retard 100 can cause side effects, although not everybody gets them.
Some side effects can be serious.
Chest pain - chest pain that may be a sign of a potentially serious allergic reaction called Kounis syndrome.
During treatment with Dicloratio retard 100, the following side effects have occurred with the following frequency:
Very common: 1 in 10 patients; common: 1 to 10 in 100 patients; uncommon: 1 to 10 in 1,000 patients; rare: 1 to 10 in 10,000 patients; very rare: less than 1 in 10,000 patients; frequency unknown (frequency cannot be estimated from available data).
If the patient experiences any of the above symptoms, they should inform their doctor immediately.
Common:occurs in 1 to 10 in 100 patients
Rare:occurs in 1 to 10 in 10,000 patients
Very rare:occurs in less than 1 in 10,000 patients
Medicines like diclofenac may slightly increase the risk of heart attack or stroke. The risk of this is more likely after taking high doses and long-term treatment. The patient should not exceed the recommended dose or treatment duration.
The patient should inform their doctor if they experience any of the above side effects.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should consult their doctor, pharmacist, or nurse.
If Dicloratio retard 100 is taken for more than a few weeks, the patient should have regular check-ups with their doctor to ensure that no unnoticed side effects have occurred.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not store above 25°C.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Ch.-B. und Verw. bis siehe Prägung - batch number and expiry date: see imprint
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Prolonged-release capsules, 100 mg.
Capsule: orange, matte with imprint "Diclo. ret.", transparent with imprint "Diclo. ret.".
Contents of the capsule: white to light yellow pellets.
PVC/Al blisters in a cardboard box.
20, 50, 100 prolonged-release capsules.
For more detailed information, the patient should contact the marketing authorization holder or parallel importer.
ratiopharm GmbH
Graf-Arco-Str. 3
89079 Ulm
Germany
Merckle GmbH
Ludwig-Merckle-Str.3
89143 Blaubeuren
Germany
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
License number in Germany, the country of export: 4369.00.03
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.